Currently available literature indicates DSC3 expression by squamous NSCLC, ovarian cancer, cervical cancer, melanoma, colorectal cancer, meningioma, esophageal squamous cell carcinoma, sarcoma, and pediatric acute lymphoblastic leukemia (51, 52, 56–58, 185–188). This evidence concerns the gene DSC3 and ovarian cancer.